Mitchell & Pahl Private Wealth’s GSK GSK Stock Holding History

Mitchell & Pahl Private Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,838	Closed	-$318K	–	156
2022 Q2	$318K	Sell	5,838 -923	-14%	-$51K	0.22%	129
2022 Q1	$368K	Sell	6,761 -457	-6%	-$24.8K	0.23%	122
2021 Q4	$398K	Buy	7,218 +2	+0%	+$104	0.26%	118
2021 Q3	$345K	Sell	7,216 -92	-1%	-$4.62K	0.25%	118
2021 Q2	$364K	Sell	7,308 -112	-2%	-$5.38K	0.26%	117
2021 Q1	$331K	Sell	7,420 -170	-2%	-$7.72K	0.26%	115
2020 Q4	$349K	Buy	+7,590	New	+$349K	0.29%	104

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Mitchell & Pahl Private Wealth's GSK Position: Q3 2022 in Review

Mitchell & Pahl Private Wealth sold out of GSK (GSK) in Q3 2022, closing a stake of 5,838 shares — an estimated $318K sold.

Mitchell & Pahl Private Wealth first reported a position in GSK in Q4 2020 and held it in 7 quarters. The position peaked at $398K in Q4 2021. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Mitchell & Pahl Private Wealth reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Mitchell & Pahl Private Wealth sold 5,838 GSK shares in Q3 2022, an estimated $318K.
Mitchell & Pahl Private Wealth first reported a position in GSK in Q4 2020 and held it in 7 quarters.
Mitchell & Pahl Private Wealth's GSK position peaked at $398K in Q4 2021.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Mitchell & Pahl Private Wealth's 13F filing for Q3 2022, filed 1 Nov 2022.